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Abstract
Acute colonic diverticulitis is one of the most common clinical conditions encountered by surgeons in the acute
setting. An international multidisciplinary panel of experts from the World Society of Emergency Surgery (WSES)
updated its guidelines for management of acute left-sided colonic diverticulitis (ALCD) according to the most
recent available literature. The update includes recent changes introduced in the management of ALCD. The new
update has been further integrated with advances in acute right-sided colonic diverticulitis (ARCD) that is more
common than ALCD in select regions of the world.
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Introduction
Acute left-sided colonic diverticulosis is common in West-
ern countries with its prevalence increasing throughout the
world, which is likely due to changes in lifestyle [1]. Al-
though left-sided colonic diverticulosis remains more com-
mon among elderly patients, a dramatic rise of its incidence
has been seen in younger age groups in recent years [2]. Re-
cent evidence suggests that lifetime risk of developing acute
left-sided colonic diverticulitis (ALCD) is about 4% among
patients with diverticulosis [3], and data from Western pop-
ulations suggest that up to one fifth of patients with acute
diverticulitis are under 50 years of age [4–6].
ALCD is a common problem encountered by Western
surgeons in the acute setting. The sigmoid colon is usu-
ally the most commonly involved part, while acute right-
sided diverticulitis (ARCD) is rarer but much more com-
mon in non-Western populations.
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Methods
The World Society of Emergency Surgery (WSES) guide-
lines for management of ALCD were published in 2016
[7]. In 2020, the guidelines were revised and updated.
The present guidelines have been developed according
to the GRADE methodology [8, 9]. The GRADE system is
a hierarchical, evidence-based tool, which systematically
evaluates the available literature and focuses on the level
of evidence based upon the types of studies included. The
quality of evidence can be marked as high, moderate, low,
or very low. This could be either downgraded in case of
significant bias or upgraded when multiple high-quality
studies showed consistent results. The highest quality of
evidence studies (systematic reviews with meta-analysis of
randomized controlled trials) was assessed first. If the
meta-analysis was of sufficient quality, it was used to an-
swer the research question. If no meta-analysis of suffi-
cient quality was found, randomized controlled trials
(RCTs) and non-randomized cohort studies (n-RCS) were
evaluated. The strength of the recommendation was based
on the level of evidence and qualified as weak or strong.
A multidisciplinary panel of experts, coordinated by a
central coordinator, was selected to serve as experts in
this 2020 update of the WSES guidelines for the man-
agement of acute left-sided colonic diverticulitis (ALCD).
The experts reviewed and updated the original list of key
questions on the diagnosis and treatment of ALCD ad-
dressed in the previous version of the guidelines.
For each statement, a consensus among the panel of
experts was reached using a Delphi approach. State-
ments were approved with an agreement of ≥ 80%.
After the approval of the statements, the expert panel
met via email to prepare and revise the definitive guidelines.
The manuscript was successively reviewed by all members
and ultimately revised as the present manuscript.
Which classification should be used in patients
with ALCD?
There are multiple classification systems for ALCD. None
has been conclusively proven to be superior in predicting
patient outcomes, and therefore, a specific recommenda-
tion cannot be provided.
ALCD ranges in severity from uncomplicated phleg-
monous diverticulitis to complicated diverticulitis in-
cluding abscess and/or perforation.
For the past three decades, the Hinchey classification
has been the most used classification in the international
literature [10].
In patients with surgical findings of abscesses and peri-
tonitis, Hinchey et al. classified the severity of acute di-
verticulitis into four levels:
1 Pericolic abscess
2 Pelvic, intra-abdominal, or retroperitoneal abscess
3 Generalized purulent peritonitis
4 Generalized fecal peritonitis
In recent years, the management of ALCD has chan-
ged dramatically.
Computer tomography (CT) imaging has become a
primary diagnostic tool in the diagnosis and staging of
patients with ALCD, and more detailed information pro-
vided by CT scans led to several modifications of the
Hinchey classification [4, 11–15].
In 1989, Neff et al. presented a new classification of ALCD
based on CT findings. It consisted of five stages, ranging
from radiological diagnosis of uncomplicated (stage 0) to
pneumoperitoneum with abundant free liquid (stage 4) [11]:
0 Uncomplicated diverticulitis; diverticula, thickening
of the wall, increased density of the pericolic fat
1 Locally complicated with local abscess
2 Complicated with pelvic abscess
3 Complicated with distant abscess
4 Complicated with other distant complications
In 2002, Ambrosetti et al. [12] classified ALCD into se-
vere or moderate disease. In this classification, the CT
scan determined the grade of severity guiding the phys-
ician in the treatment of acute complications. Moderate
diverticulitis was defined by wall thickening of ≥ 5 mm
and signs of pericolic fat inflammation. Severe diverticu-
litis was defined by wall thickening accompanied by ab-
scess, extraluminal gas, or extraluminal contrast:
1. Moderate diverticulitis
(a) Localized sigmoid wall thickening (≥ 5 mm)





In 2005, Kaiser et al. [13] modified the Hinchey classi-
fication according to specific CT findings:
Stage 0: mild clinical diverticulitis
Stage 1a: confined pericolic inflammation
Stage 1b: confined pericolic abscess
Stage 2: pelvic or distant intra-abdominal abscess
Stage 3: generalized purulent peritonitis
Stage 4: fecal peritonitis at presentation
In 2013, Mora Lopez et al. proposed [14] a modifica-
tion of the previous Neff classification dividing Neff
stage 1 into stage 1a (localized pneumoperitoneum in
the form of gas bubbles) and 1b (abscess < 4 cm).
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0Uncomplicated diverticulitis. Diverticula, thickening
of the wall, increased density of the pericolic fat
1Locally complicated diverticulitis
1aLocalized pneumoperitoneum in the form of gas bubbles
1bAbscess (< 4 cm)
2Complicated diverticulitis with pelvic abscess. Ab-
scess > 4 cm in pelvis
3Complicated diverticulitis with distant abscess. Ab-
scess in abdominal cavity (outside pelvis)
4Complicated diverticulitis with other distant compli-
cations. Abundant pneumoperitoneum and/or intra-
abdominal free liquid
Recently, Sallinen et al. [15] published an interesting
retrospective study of patients treated for ALCD, setting
the stage for the treatment of acute diverticulitis based
on clinical, radiologic, and physiologic parameters:
1Uncomplicated diverticulitis
2Complicated diverticulitis with small abscess (< 6 cm)
3Complicated diverticulitis with large abscess (≥ 6 cm)
or distant intraperitoneal or retroperitoneal gas
4Generalized peritonitis without organ dysfunction
5Generalized peritonitis with organ dysfunction
Finally, a proposal for a CT-guided classification of
ALCD was published in 2015 by the WSES acute diver-
ticulitis working group [7].
It is a simple classification system of ALCD based on CT
scan findings. It may guide clinicians in the management of
acute diverticulitis and may be universally accepted for day
to day practice. The WSES classification divides acute di-
verticulitis into 2 groups: uncomplicated and complicated.
In the event of uncomplicated acute diverticulitis, the
infection only involves the colon and does not extend to
the peritoneum. In the event of complicated acute diver-
ticulitis, the infectious process proceeds beyond the colon.
Complicated acute diverticulitis is divided into 4 stages,
based on the extension of the infectious process:
Uncomplicated
0Diverticula, thickening of the wall, increased density
of the pericolic fat
Complicated
1APericolic air bubbles or small amount of pericolic
fluid without abscess (within 5 cm from inflammed
bowel segment)
1BAbscess ≤ 4 cm
2AAbscess > 4 cm
2BDistant gas (> 5 cm from inflammed bowel segment)
3Diffuse fluid without distant free gas
4Diffuse fluid with distant free gas
What is the best way to make a diagnosis of
ALCD?
In patients with suspected ALCD, we suggest a complete as-
sessment of the patients using clinical history, signs, labora-
torial inflammation markers, and radiological findings
(weak recommendation based on very low-quality evidence,
2D).
In patients with suspected, ALCD we suggest against
diagnosis based only on clinical examination (weak rec-
ommendation based on very low-quality evidence, 2D).
Clinical findings of patients having ALCD include
acute pain or tenderness in the left lower quadrant that
may be associated with increased inflammatory markers,
including C-reactive protein (CRP) and white blood cell
count (WBC). Clinical diagnosis of ALCD usually lacks
accuracy. In a prospective analysis [16] conducted on
802 consecutive patients who presented with abdominal
pain to the emergency department, positive and negative
predictive values of clinical diagnosis were 0.65 and 0.98,
respectively. Additional cross-sectional imaging had a
positive and negative predictive value of 0.95 and 0.99,
respectively. Additional radiology examinations im-
proved the diagnostic accuracy in 37% of the patients,
but changed the management in only 7%.
In 2010, using logistic regression analysis, Laméris
et al. [17] developed a clinical decision rule for diagnosis
of ALCD, based on 3 criteria: (1) direct tenderness only
in the left lower quadrant, (2) CRP > 50mg/l, and (3) ab-
sence of vomiting. Of 126 clinically suspected patients
enrolled in this prospective study, 30 patients had all 3
features (24%), of whom 29 had a final diagnosis of acute
diverticulitis (97%; 95% CI 83–99%). Of the 96 patients
without all 3 features, 45 (47%) did not have diverticu-
litis. In a quarter of patients with suspected diverticulitis,
the diagnosis could be made clinically based on the com-
bination of the three criteria.
Andeweg et al. in 2011 [18], using retrospective data
from 287 patients, developed a clinical scoring system
for the diagnosis of ALCD with diagnostic accuracy of
86%. It was based on independent predictors of ALCD
including age, a clinical history of one or more previous
episodes, localization of symptoms in the lower left ab-
domen, aggravation of pain on movement, the absence
of vomiting, localization of abdominal tenderness on
examination in the lower left abdomen, and C-reactive
protein of 50 mg/l or higher.
CRP has been identified as a useful biomarker of in-
flammation, and it may be useful in the prediction of the
clinical severity of acute diverticulitis as demonstrated
by several recent studies [19–21]. To investigate the
value of CRP and of other laboratory parameters of the
patients in the prediction of the clinical severity of acute
diverticulitis, a retrospective study was published in
2014 [19]. A CRP cutoff value of 170 mg/l significantly
discriminated severe from mild diverticulitis (87.5% sen-
sitivity, 91.1% specificity, area under the curve 0.942, p <
0.00001). The authors concluded that CRP is a useful
tool in the prediction of the clinical severity of acute di-
verticulitis. A mild episode is very likely in patients with
Sartelli et al. World Journal of Emergency Surgery           (2020) 15:32 Page 3 of 18
CRP less than 170 mg/l. Those with higher CRP values
have a greater probability of undergoing surgery or per-
cutaneous drainage.
In another study, the diagnostic value of serological in-
fection markers and body temperature, in discriminating
complicated from uncomplicated diverticulitis, was
assessed [20]. A total of 426 patients were included in
this study of which 364 (85%) presented with uncompli-
cated and 62 (15%) with complicated diverticulitis. Only
CRP was of sufficient diagnostic value (area under the
curve 0.715). The median CRP in patients with compli-
cated diverticulitis was significantly higher than in pa-
tients with uncomplicated disease (224 mg/l, range 99–
284, vs. 87 mg/l, range 48–151, respectively). Patients
with a CRP of 25 mg/l had a 15% chance of having com-
plicated diverticulitis. This increased from 23% at a CRP
value of 100 mg/l to 47% for 250 mg/l or higher. The op-
timal threshold was reached at 175 mg/l with a positive
predictive value of 36%, negative predictive value of 92%,
sensitivity of 61%, and specificity of 82%.
Mäkelä et al. [21] published a study comparing the
CRP values of 350 patients who presented for the first
time with symptoms of acute diverticulitis with the CT
findings and clinical parameters by means of both uni-
variate and multivariate analyses. CRP cutoff value of
149.5 mg/l significantly discriminated acute uncompli-
cated diverticulitis from complicated diverticulitis (speci-
ficity 65%, sensitivity 85%, area under the curve 0.811, p
= 0.0001). In multivariate analysis, a CRP value over 150
mg/l and old age were independent risk factors for acute
complicated diverticulitis. The mean CRP value was sig-
nificantly higher in the patients who died (mean CRP of
207 mg/l) than in those who survived (mean CRP of 139
mg/l). In addition, a CRP value over 150 mg/l and free
abdominal fluid in CT were independent variables pre-
dicting postoperative mortality. The study confirmed
that CRP is useful for predicting the severity of acute di-
verticulitis on admission. The authors concluded that
patients with a CRP value higher than 150 mg/l have an
increased risk of complicated diverticulitis and should
always undergo a CT examination.
In 2018, a prospective study of patients with ALCD
was published [22]. All patients underwent CT. Index
parameters obtained at the initial evaluation in the
emergency unit were analyzed to assess the association
with the outcome. Ninety-nine patients were analyzed.
Eighty-eight had mild radiological grading (Hinchey Ia/
Ib), and 11 had severe radiological grading (Hinchey >
Ib) (median index CRP 80 mg/l vs. 236 mg/l, p < 0.001).
The median CRP level for Hinchey III/IV was 258.5 mg/l
(201–297 mg/l). WBC, neutrophils/lymphocytes, serum
creatinine, serum glucose, generalized peritonitis, gener-
alized abdominal tenderness, urinary symptoms, and
index CRP were related to severe disease. Index CRP
was the only independent predictor for Hinchey > Ib (p
= 0.038). The optimal cutoff value calculated by receiver
operating characteristic curve analysis was found to be
173 mg/l (sensitivity 90.9%, specificity 90.9%, p < 0.001).
All patients who underwent radiologic-guided percutan-
eous or surgery had an index CRP > 173mg/l and
Hinchey > Ib. However, the authors concluded that CRP
should not be used as a predictor of severity if there are
concomitant conditions that may affect its baseline
levels.
The expert panel states that in very acutely onset dis-
ease, CRP values might not have rised yet, since there is
a delay of 6–8 h from the onset of the disease, reaching
peak at 48 h. Therefore, caution should be used in using
low CRP as excluding out acute diverticulitis [23].
What is the best imaging technique in patients
with suspected ALCD? What is the role of
ultrasound (US) in patients with ALCD?
In patients with suspected ALCD, we suggest contrast-
enhanced CT scan of the abdomen as the imaging tech-
nique of first choice (weak recommendation based on
moderate-quality evidence, 2B).
We suggest to use US in the initial evaluation of pa-
tients with suspected ALCD where it is performed by an
expert operator. It has wide availability and easy accessi-
bility. A step-up approach with CT performed after an
inconclusive or negative US may be a safe approach for
patients suspected of acute diverticulitis (weak recom-
mendation based on moderate-quality evidence, 2B).
Radiological imaging techniques that are used for diag-
nosing ALCD in the emergency setting are US and CT.
Currently, CT is the established method of choice when
compared to US and most guidelines cite the high ac-
curacy and other advantages of CT. This approach is the
gold standard for both the diagnosis and the staging of
patients with ALCD due to its excellent sensitivity and
specificity [24–26]. CT scan can also rule out other diag-
noses such as ovarian pathology, or leaking aortic or iliac
aneurysm.
CT findings in patients with ALCD may include diver-
ticulosis with associated colon wall thickening, fat strand-
ing, phlegmon, extraluminal gas, abscess formation, or
intra-abdominal free fluid. CT imaging can go beyond ac-
curate diagnosis of ALCD. CT criteria may also be used to
determine the grade of severity and may drive treatment
planning of patients [27]. US is a real-time dynamic exam-
ination with wide availability and easy accessibility [28]. Its
limitations include operator dependency, poor assessment
in obese patients, and difficulty in the detection of free gas
and deeply located abscesses [29].
A systematic review and meta-analysis of studies [30]
that reported diagnostic accuracy of the clinical diagno-
sis and diagnostic modalities in patients with suspected
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diverticulitis was published in 2014. Summary sensitivity
estimates for US were 90% (95% CI 76–98%) versus 95%
(95% CI 91–97%) for CT (p = 0.86). Summary specificity
estimates for US were 90% (95% CI 86–94%) versus 96%
(95% CI 90–100%) for CT (p = 0.04).
Although CT is the most sensitive imaging investiga-
tion for patients with suspected acute diverticulitis, a
step-up approach with CT performed after an inconclu-
sive or negative US has been proposed as safe and alter-
native approach for patients with suspected acute
diverticulitis [30, 31].
Magnetic resonance imaging, which is not constrained
by the operator dependency limitation of compared to
US [32, 33], until now is currently difficult to perform at
in the emergency department.
Are immunocompromised patients with ALCD at
risk for failure of standard, non-operative
treatment?
We suggest that immunocompromised patients with
ALCD be considered at high risk for failure of standard,
non-operative treatment (weak recommendation based
on very low-quality evidence, 2D).
Immunocompromised patients are at increased risk
for complicated ALCD [34–37]. Immunocompromised
patients may fail standard, non-operative treatment. As
such, most of these patients require urgent surgical
intervention, and this is associated with a significantly
higher mortality rate [38].
A recent study by Biondo et al. [39] analyzed the rela-
tionship between the different causes of immunosuppres-
sion (IMS) and ALCD. Immunocompromised patients
were divided in 5 groups according to the causes of IMS:
group I, chronic corticosteroid therapy; group II, trans-
plant patients; group III, malignant neoplasm disease;
group IV, chronic renal failure; and group V, other im-
munosuppressant treatments. The rate of emergency sur-
gery was high (39.3%), and it was needed more frequently
in group I (chronic corticosteroid therapy). In this study,
postoperative mortality was of 31.6% and recurrence rate
after successful non-operative management occurred in
30 patients (27.8%).
Should antibiotics be recommended in
immunocompetent patients with uncomplicated
acute diverticulitis?
In immunocompetent patients with uncomplicated diver-
ticulitis without signs of systemic inflammation, we rec-
ommend to not prescribe antibiotic therapy (strong
recommendation based on high-quality evidence, 1A).
In patients requiring antibiotic therapy, we recommend
oral administration whenever possible, primarily, be-
cause an early switch from intravenous to oral therapy
may facilitate a shorter inpatient length of stay (strong
recommendation based on moderate-quality evidence,
1B).
The definition of uncomplicated acute diverticulitis is
often vague and poorly defined. Uncomplicated acute di-
verticulitis is defined as localized diverticular inflamma-
tion without any abscess or perforation. A universally
accepted classification divides intra-abdominal infections
(IAIs) into complicated and uncomplicated [40]. In un-
complicated IAIs, the infection only involves a single
organ and does not extend to the peritoneum, while in
complicated IAIs, the infectious process extends beyond
the organ, causing either localized or diffuse peritonitis
[40]. For a better definition of acute diverticulitis in
these guidelines, we use the term complicated and un-
complicated according to the classification of IAIs.
Uncomplicated acute diverticulitis is an anatomically
confined inflammatory process. CT findings include di-
verticula, thickening of the wall, and increased density of
the pericolic fat. Patients with uncomplicated diverticu-
litis usually have an indolent course with a low incidence
of subsequent complications.
The utility of antibiotics in acute uncomplicated acute
diverticulitis has been a point of controversy. In recent
years, several studies demonstrated that antimicrobial
treatment was not superior to withholding antibiotic
therapy, in terms of clinical resolution, in patients with
mild unperforated diverticulitis [41]. The current con-
sensus is that uncomplicated acute diverticulitis may be
a self-limiting condition in which local host defenses can
manage the inflammation without antibiotics in im-
munocompetent patients. In this context, antibiotics are
not necessary in the treatment of uncomplicated disease.
A multicenter randomized trial was published in 2012
by Chabok et al. involving ten surgical departments in
Sweden and one in Iceland recruiting 623 patients with
computed tomography-confirmed acute uncomplicated
left-sided diverticulitis [42]. Patients were randomized to
treatment with (314 patients) or without (309 patients) an-
tibiotics. Antibiotic treatment for acute uncomplicated di-
verticulitis neither accelerated recovery nor prevented
complications or recurrence. Therefore, antibiotics should
be reserved for the treatment of complicated diverticulitis.
A prospective, single-arm, study overviewed [43] the
safety and efficacy of symptomatic (non-antibiotic) treat-
ment for CT-proven uncomplicated acute diverticulitis
during a 30-day follow-up period. Overall, 161 patients
were included in the study, and 153 (95%) completed
the 30-day follow-up. A total of 14 (9%) patients had
pericolic gas. Altogether, 140 (87%) patients were treated
as outpatients, and 4 (3%) of them were admitted to the
hospital during the follow-up. The primary outcome
measure of the study was to find the incidence of com-
plicated diverticulitis. None of the patients developed
complicated diverticulitis or required surgery, but 2 days
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(median) after inclusion, antibiotics were given to 14
(9%, 6 orally, 8 intravenously) patients. A recent Dutch
randomized controlled trail of observational versus sys-
temic antibiotic treatment (DIABOLO trial) [43] for a
first episode of CT-proven ALCD Hinchey stages 1a and
1b confirmed that observational treatment without anti-
biotics did not prolong recovery and could be considered
appropriate in these patients.
This study included 22 clinical sites involving 528 pa-
tients; Hinchey modified stages 1a (confined pericolic in-
flammation or phlegmon) to 1b (pericolic or mesocolic
abscess) and Ambrosetti’s “mild/moderate” diverticulitis
stage confirmed within 24 h by CT were included. Pa-
tients with previous diverticulitis, higher Hinchey stages,
or “severe” diverticulitis on Ambrosetti’s classification
were excluded. The antibiotic treatment was a 10-day
course of IV amoxicillin-clavulanic acid, 1200mg four
times daily for at least 48 h. After 48 h, the administra-
tion route could be switched to per os, 625 mg three
times daily. For observational treatment, patients had to
meet the criteria of tolerating a normal diet, temperature
less than 100.4 °F, a pain score below 4 on a visual
analogue scale (using only acetaminophen for pain con-
trol), and the ability to support self at the same level as
before illness. If the patient deteriorated, CT was re-
peated and antibiotic treatment was started if the
temperature rose above 102.2 °F, blood cultures were
positive, or the patient was septic.
No significant differences between the observation and
antibiotic treatment groups were found for secondary
endpoints: complicated diverticulitis (3.8% vs. 2.6%, re-
spectively; p = 0.377), ongoing diverticulitis (7.3% vs.
4.1%, respectively; p = 0.183), recurrent diverticulitis
(3.4% vs. 3.0%, respectively; p = 0.494), sigmoid resection
(3.8% vs. 2.3%, respectively; p = 0.323), readmission
(17.6% vs. 12.0%, respectively; p = 0.148), adverse events
(48.5% vs. 54.5%, respectively; p = 0.221), and mortality
(1.1% vs. 0.4%, respectively; p = 0.432). Hospital stay was
significantly shorter in the observation group (2 vs. 3
days; p = 0.006). However, even if no significant differ-
ences between Hinchey stages 1a and 1b diverticulitis
were found, the vast majority of patients included had a
diagnosis of Hinchey stage 1a ALCD (90.1% in the ob-
servational and 94% in the antibiotic-treated group) with
only a small percentage of patients with Hinchey stage 1
stage 1b diverticulitis. Based on these results, the au-
thors concluded that antibiotics can be safely omitted
in patients with a first episode of uncomplicated
(Hinchey 1a) ALCD. Similar results were found for
Hinchey 1b diverticulitis. However, since the trial
lacked power to detect smaller subgroup effects and
there are no other reports in literature, the authors
concluded that observational treatment should be lim-
ited to Hinchey 1a cases [44].
More recently, the long-term effects of omitting anti-
biotics in uncomplicated ALCD were assessed after 24
months’ follow-up of the DIABOLO trial [44]. Complete
case analyses showed no difference in rates of recurrent
diverticulitis (15.4% in the observational group vs. 14.9%
in the antibiotic group; p = 0.885), complicated diver-
ticulitis (4.8% vs. 3.3%; p = 0.403), and sigmoid resection
(9.0% vs. 5.0%; p = 0.085). Young patients (< 50 years)
and patients with a pain score at presentation of 8 or
higher on a visual analogue pain scale were at risk for
complicated or recurrent diverticulitis. In this multivari-
able analysis, treatment type (with or without antibiotics)
was not an independent predictor for complicated or re-
current diverticulitis [45].
Although the above studies have shown there is lim-
ited evidence that antibiotics should be routinely admin-
istered to patients with uncomplicated diverticulitis, it is
understood that disease severity varies in uncomplicated
diverticulitis and that further studies are needed to bet-
ter risk-stratify these patients in order to determine the
appropriate treatment course.
The high mortality associated with sepsis requires cli-
nicians to maintain a high index of clinical suspicion, in
the conditions that predispose to sepsis in high-risk pa-
tients [46]. The expert panel suggests antibiotic therapy
covering Gram-negative bacilli and anaerobes in patients
with radiological documented uncomplicated acute di-
verticulitis associated with systemic manifestations of in-
fection or in high-risk patients such as
immunocompromised patients, elderly patients, and
those with comorbidities.
If antibiotic therapy is necessary, oral administration
of antibiotics may be equally as effective as intravenous
administration. An expeditious switch from intravenous
to oral may allow a rapid patient discharge.
A randomized controlled trial (RCT) of oral versus
intravenous therapy for clinically diagnosed acute un-
complicated diverticulitis was published in 2009 [47].
Oral and intravenous regimens utilizing ciprofloxacin
and metronidazole were compared. There were 41 pa-
tients in the oral arm and 38 in the IV arm (n = 79). No
patients had to be converted to intravenous antibiotics
from the oral group. There was a complete resolution of
symptoms in both groups. No studies have examined the
value of dietary restriction or bed rest [48].
Could patients with uncomplicated ALCD be
treated as outpatient?
We suggest management in an outpatient setting for pa-
tients with uncomplicated ALCD and no comorbidities.
We suggest re-evaluation within 7 days. If the clinical
condition deteriorates, re-evaluation should be carried
out earlier (weak recommendation based on moderate-
quality evidence, 2B).
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Patients with uncomplicated acute diverticulitis symp-
toms without significant comorbidities, who are able to
take fluids orally and manage themselves at home, can
be treated as outpatients. They should be re-evaluated
within 7 days from the time of the diagnosis. However, if
the clinical condition deteriorates, re-evaluation should
be carried out earlier. Patients with significant comor-
bidities and unable to take fluids orally should be treated
in hospital with intravenous fluids.
Etzioni et al. [49] in 2010 published a retrospective
analysis, demonstrating that outpatient treatment was ef-
fective for the vast majority (94%) of patients suffering
from acute diverticulitis. A systematic review on out-
patient management of acute uncomplicated acute diver-
ticulitis was recently published [50]. Jackson et al.
concluded that current evidence suggested that a more
progressive, ambulatory-based approach to the majority
of cases of acute uncomplicated acute diverticulitis was
justified. Rodríguez-Cerrillo et al. [51] have recently
shown that also elderly patients with comorbidities can
be safely treated at home avoiding hospital admission.
The DIVER trial [52] has demonstrated that outpatient
treatment may be safe and effective in selected patients
with uncomplicated acute diverticulitis and can reduce
the costs without negatively influencing the quality of
life of these patients. This multicenter, RCT included pa-
tients older than 18 years with acute uncomplicated di-
verticulitis. All the patients underwent abdominal CT.
The first dose of antibiotic was given intravenously to all
patients in the emergency department, and then, patients
were either admitted to hospital or discharged. Among a
total of 132 patients, four patients in those admitted to
hospital and three patients in those discharged to home
management developed treatment failure (there were no
differences between the groups (p = 0.62)). The overall
health care cost per episode was 3 times less in the out-
patient treated group, with significant costs savings of
€1124.70 per patient. No differences were observed be-
tween the groups in terms of quality of life.
A systematic review including 21 studies (11 prospect-
ive, 9 retrospective, and only 1 randomized trial) with
1781 patients who had outpatient management of ALCD
was recently published [53]. The meta-analysis con-
cluded that outpatient management is safe, and the over-
all failure rate in an outpatient setting was 4.3% (95% CI
2.6–6.3%). Location of diverticulitis is not a selection cri-
terion for an outpatient strategy (p = 0.512). The other
subgroup analyses did not report any factors that influ-
ence the rate of failure: previous episodes of acute diver-
ticulitis (p = 0.163), comorbidities (p = 0.187), pericolic
gas (p = 0.653), intra-abdominal abscess (p = 0.326),
treatment according to a registered protocol (p = 0.078),
type of follow-up (p = 0.700), type of antibiotic treat-
ment (p = 0.647), or diabetes (p = 0.610). In patients
who failed outpatient treatment, the majority had pro-
longed antibiotic therapy and only few had percutaneous
drainage for an abscess (0.13%) or surgical intervention
for perforation (0.06%). However, these results should be
interpreted with some caution because of the low quality
of available data. The data reported suggested that out-
patient management is safe if associated with an accur-
ate selection of patients (40%); no subgroup analysis
demonstrated significant differences between groups (in-
cluding comorbidities, previous episode and diabetes).
The main limitations of the findings of the present re-
view concern their applicability in common clinical prac-
tice as it was impossible to identify strict criteria of
failure.
Another review about outpatient management of
ALCD was published in 2017 [54]. The search yielded
192 publications. Of these, 10 studies met the inclusion
criteria including 1 RCT, 6 clinical controlled trials, and
3 case series. There was no difference in failure rates of
medical treatment (6.5 vs. 4.6%, p = 0.32) or in recur-
rence rates (13.0 vs. 12.1%, p = 0.81) between those re-
ceiving ambulatory care and inpatient care for
uncomplicated diverticulitis. Ambulatory treatment was
associated with an estimated daily cost savings of be-
tween €600 and €1,900 per patient treated. Meta-
analysis of data was not possible due to heterogeneity in
study designs and inclusion criteria.
What is the best treatment for patients with acute
diverticulitis with CT findings of pericolic gas?
In patients with CT findings of pericolic extraluminal
gas, we suggest a trial of non-operative treatment with
antibiotic therapy (weak recommendation based on low-
quality evidence, 2C).
High mortality associated with sepsis requires main-
taining a high index of clinical suspicion for deterior-
ation and more aggressive management. WSES expert
panel recommends antibiotic therapy in patients with
pericolic extraluminal gas [27]. A sub-analysis of the DIA-
BOLO trial was recently published [55]. All patients with
Hinchey 1a diverticulitis and with isolated pericolic gas on
CT were identified. Pericolic gas was defined as gas lo-
cated < 5 cm from the affected segment of colon. The pri-
mary outcome of the study was failure of non-operative
management that was defined as need for percutaneous
abscess drainage or emergency surgery within 30 days
after presentation. A multivariate logistic regression ana-
lyses of clinical, radiological, and laboratorial parameters
with respect to treatment failure was performed. A total of
109 patients were included. Fifty-two (48%) patients were
treated with antibiotics. Nine (8%) patients failed non-
operative management, seven (13%) in the antibiotic treat-
ment group and two (4%) in the non-antibiotic group (p =
0.083). Only increased CRP level at presentation was an
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independent predictor for treatment failure. The authors
concluded that non-operative treatment in diverticulitis
patients with isolated pericolic gas is a suitable treatment
strategy. However, due to the low event rate, it remains
uncertain whether antibiotic treatment is necessary in pa-
tients with isolated pericolic gas.
What is the best treatment for patients with a
small diverticular abscess (< 4–5 cm)? What is the
best treatment for patients with large diverticular
abscess?
For patients with a small (< 4–5 cm) diverticular abscess,
we suggest an initial trial of non-operative treatment
with antibiotics alone (weak recommendation based on
low-quality evidence, 2C).
We suggest to treat patients with large abscesses with
percutaneous drainage combined with antibiotic treat-
ment; whenever percutaneous drainage of the abscess is
not feasible or not available, we suggest to initially treat
patients with large abscesses with antibiotic therapy
alone, clinical conditions permitting. Alternatively, an
operative intervention is required (weak recommendation
based on low-quality evidence, 2C).
Approximately 15–20% of patients admitted with
acute diverticulitis have an abscess on CT scan [56]. The
treatment of abscess always requires antibiotic therapy.
If the abscess is limited in size, systemic antibiotic ther-
apy alone is considered safe and effective in removing
the abscess and solving acute inflammation with a
pooled failure rate of 20% and a mortality rate of 0.6%
[57].
When abscess diameter is larger, antibiotics could fail
to reach the adequate concentration inside the abscess
leading to an increased failure rate.
The size of 4–5 cm may be a reasonable limit between
antibiotic treatment alone, versus percutaneous drainage
combined with antibiotic treatment in the management
of diverticular abscesses [58–62]. When the patient’s
clinical conditions allow it and percutaneous drainage is
not feasible, antibiotic therapy alone can be considered.
However, careful clinical monitoring is mandatory. A high
suspicion for surgical control of the septic source should
be maintained and a surgical treatment should be per-
formed if the patient shows a worsening of inflammatory
signs or the abscess does not reduce with medical therapy.
There are currently no randomized studies available on
the best treatment of intra-abdominal abscess from acute
diverticulitis, and current recommendations are based
only on observational studies. A retrospective study com-
paring outcomes of selected patients treated with initial
antibiotics alone versus percutaneous drainage was pub-
lished in 2015 by Elagili et al. [63]. All patients with diver-
ticular abscess ≥ 3 cm in diameter treated in a single
institution in 1994–2012 with percutaneous drainage or
antibiotics alone followed by surgery were identified from
an institutional diverticular disease database. Groups were
compared based on patient and disease characteristics,
treatment failures, and postoperative outcomes. Thirty-
two patients were treated with antibiotics alone because of
either technically impossible percutaneous drainage or
surgeon preference, while 114 underwent percutaneous
drainage. Urgent surgery was required in 8 patients with
persistent symptoms during treatment with antibiotics
alone (25%) and in 21 patients (18%) after initial percu-
taneous drainage (p = 0.21). Patients treated with antibi-
otics had a significantly smaller abscess diameter (5.9 vs.
7.1 cm, p = 0.001) and shorter interval from initial treat-
ment to sigmoidectomy (mean 50 vs. 80 days, p = 0.02).
Postoperative complications following antibiotics alone
were significantly less severe than after percutaneous
drainage based on the Clavien-Dindo classification (p =
0.04).
In patients displaying an appropriate clinical improve-
ment, the drainage catheter can be removed when the
output has ceased or decreased substantially. In doubtful
cases, a CT scan can be performed with water-soluble
contrast via the percutaneous drainage catheter prior to
drain removal. If no identifiable cavity remains, the cath-
eter should be removed. If resolution of the abscess is
not reached and the patient has no clinical improve-
ment, further drainage or catheter repositioning might
be indicated and may eventually necessitate surgery.
Should an early colonic evaluation be planned in
patients treated non-operatively for a diverticular
abscess? Should an early colonic evaluation be
recommended for patients with a CT-proved
uncomplicated acute diverticulitis treated non-
operatively?
In patients with diverticular abscesses treated non-
operatively, we suggest to plan an early colonic evalu-
ation (4–6 weeks) (weak recommendation based on low-
quality evidence, 2C).
In patients with CT-proven uncomplicated diverticu-
litis treated non-operatively, we do not recommend rou-
tine colonic evaluation (weak recommendation based on
moderate-quality evidence, 2B).
Colonic localized abscess is an uncommon, but pos-
sible, presentation of an occult colon malignancy, and it
may mimic complicated diverticular disease [64, 65]. It
has been demonstrated that the risk of malignancy after
a CT-proven uncomplicated diverticulitis is low and, in
the absence of other indications, routine colonoscopy
may not be necessary. A systematic review investigating
the rate of colorectal cancer (CRC) found by colonos-
copy after an episode of uncomplicated diverticulitis was
published in 2014 [66]. Nine studies met the inclusion
criteria and included a total number of 2490 patients
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with uncomplicated diverticulitis. Subsequent colonos-
copy after an episode of uncomplicated diverticulitis was
performed in 1468 patients (59%). Seventeen patients
were diagnosed with CRC, having a prevalence of 1.16%
(95% confidence interval 0.72–1.9% for CRC). Hyper-
plastic polyps were seen in 156 patients (10.6%), low-
grade adenoma in 90 patients (6.1%), and advanced ad-
enoma in 32 patients (2.2%). The results of this review
demonstrate that unless colonoscopy is regarded for
screening in individuals aged 50 years and older, routine
colonoscopy in the absence of other clinical signs of
CRC is not required in patients following an episode of
acute uncomplicated diverticulitis.
Another systematic review and meta-analysis on the
role of routine colonic evaluation after radiologically
confirmed acute diverticulitis was published in 2014
[67]. Eleven studies from 7 countries were included in
the analysis. Among 1970 patients, cancer was only
found in 22 (0.01%) cases. The risk of malignancy after a
radiologically proven episode of acute uncomplicated di-
verticulitis was low. Patients with complicated diverticu-
litis had a significant risk of CRC at subsequent colonic
evaluation.
A retrospective study of 633 patients with acute diver-
ticulitis diagnosed by CT was published in 2014 [68]. Of
the 663 patients, 97 patients underwent emergency re-
section, while 536 patients were treated non-operatively,
394 of whom subsequently underwent colonoscopy. The
findings showed 17 cancers (2.7%) in patients with an
initial diagnosis of acute diverticulitis. As shown by CT,
16 cancer patients (94%) had an abscess, while one pa-
tient had pericolic extraluminal gas but no abscess. Of
the patients with an abscess, 11.4% had cancer mimick-
ing acute diverticulitis. No cancer was found in the pa-
tients with uncomplicated diverticulitis.
What is the role of non-operative treatment in
patients with CT findings of distant gas without
diffuse intra-abdominal fluid?
In patients with CT findings of distant free gas without
diffuse intra-abdominal fluid, we suggest a non-operative
treatment in selected patients only if a close follow-up
can be performed (weak recommendation based on very
low-quality evidence, 2D).
Although most patients hospitalized for acute diver-
ticulitis can be managed by non-operative treatment, up
to 25% may require urgent operative intervention [69].
Patients with diffuse peritonitis are typically critically ill
patients and require prompt fluid resuscitation, anti-
biotic administration, and surgery. While the absolute
prevalence of perforated diverticulitis complicated by
generalized peritonitis is low, it is associated with signifi-
cant postoperative mortality, regardless of selected surgi-
cal strategy.
Despite CT findings of distant free gas (a known pre-
dictor of failure of non-operative treatment [27]), Dhar-
marajan et al. [70] described a high success rate for non-
operative management in patients with acute diverticu-
litis and a pneumoperitoneum, excluding those with
hemodynamic instability. Sallinen et al. [71] reported re-
sults of non-operative management in patients with CT
verified extraluminal gas. The study showed that non-
operative treatment was feasible therapy only for
hemodynamically stable patients with pericolic extra-
luminal gas or with small amount of distant intraperito-
neal gas in the absence of clinical diffuse peritonitis or
fluid in the fossa Douglas. Occurrence of large amount
of distant intraperitoneal gas or distant retroperitoneal
gas even in the absence of clinical generalized peritonitis
was associated with high failure rate (57–60%) of non-
operative management. Moreover, nearly 60% patients
with distant intraperitoneal gas were primarily treated by
surgery.
Highly selected group of patients at this stage may be
treated by conservative treatment. However, it may be
associated with a significant failure rate and a careful
clinical and CT monitoring is mandatory [20]. Suggested
intervention for patients at this stage should be surgical
resection and anastomosis with or without stoma in
stable patients without comorbidities, and Hartmann’s
procedure (HP) in unstable patients or in patients with
multiple comorbidities [27].
Should laparoscopic lavage and drainage be
recommended in patients with diffuse peritonitis
due to diverticular perforation?
We suggest performing laparoscopic peritoneal lavage
and drainage only in very selected patients with general-
ized peritonitis. It is not considered as the first line treat-
ment in patients with peritonitis from acute colonic
diverticulitis (weak recommendation based on high-
quality evidence, 2A).
A minimally invasive approach using laparoscopic
peritoneal lavage and drainage has been debated in re-
cent years as an alternative to colonic resection [72]. It
can potentially avoid a stoma in patients with diffuse
peritonitis. It consists of the laparoscopic aspiration of
pus followed by abdominal lavage and the placement of
abdominal drains, which remain for many days after the
procedure. In 2013, a Dutch retrospective analysis of 38
patients [73] treated by laparoscopic lavage was pub-
lished highlighting some doubts about this procedure to
treat critically ill patients. In seven patients, this ap-
proach did not control abdominal sepsis, two patients
died of multiple organ failure and five ones required fur-
ther surgical interventions (three Hartmann resection,
one diverting stoma, and one perforation closure). One
of these died from aspiration, and the remaining four
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experienced prolonged and complicated hospital stay.
Multiple comorbidities, IMS, a high CRP level, and/or a
high Mannheim Peritonitis Index were also predictors of
a high risk of failure. The authors concluded that patient
selection was of utmost importance and identification of
an overt sigmoid perforation is of critical importance.
Great debate is still open on this topic, mainly due to
the discrepancy and sometime disappointing results of
the latest prospective trials such as SCANDIV, Ladies,
and DILALA trials [74–76]
In 2014, the first results from the RCT DILALA were
published [74]. Initial diagnostic laparoscopy showing
Hinchey III disease was followed by randomization be-
tween laparoscopic lavage and colon resection and
stoma. Morbidity and mortality after laparoscopic lavage
did not differ when compared with the Hartmann pro-
cedure. Laparoscopic lavage resulted in shorter operating
time, shorter time in the recovery unit, and shorter hos-
pital stay with the avoidance of a stoma. In this trial, lap-
aroscopic lavage as treatment for patients with
perforated diverticulitis Hinchey III disease was feasible
and safe in the short-term. In 2015, the results of SCAN-
DIV study were published [75]. Among patients with
likely perforated diverticulitis and undergoing emergency
surgery, the use of laparoscopic lavage vs. primary resec-
tion did not reduce severe postoperative complications
and led to worse outcomes in secondary endpoints. These
findings do not support laparoscopic lavage for treatment
of perforated diverticulitis. In the same year, the result of
LADIES study was published. This showed that laparo-
scopic lavage was not superior to sigmoidectomy for the
treatment of purulent perforated diverticulitis [76].
After their publication, the results of the three studies
were summarized in six different meta-analyses, with simi-
lar findings [77–82]. When compared with emergency sur-
gery with resection, laparoscopic lavage in Hinchey III
acute diverticulitis shows a comparable mortality but is as-
sociated with a failure rate with a significantly augmented
need for reoperation due to the failure of the treatment and
to intra-abdominal abscess formation. Long-term results
were similar, with no difference in morbidity and mortality.
Several controversies remain about laparoscopic lavage
and drainage. It may be an acceptable alternative in se-
lected patients [83]; however, it cannot be considered the
first line treatment in patients with diverticular peritonitis.
Should primary anastomosis with or without
protecting stoma be preferred instead of
Hartmann’s procedure in patients with diffuse
peritonitis from diverticular perforation?
We recommend Hartmann’s procedure (HP) for man-
aging diffuse peritonitis in critically ill patients and in se-
lected patients with multiple comorbidities (strong
recommendation based on low-quality evidence, 2B).
In clinically stable patients with no comorbidities, we
suggest primary resection with anastomosis with or with-
out a diverting stoma (weak recommendation based on
low-quality evidence, 2B).
HP has been considered the procedure of choice in pa-
tients with generalized peritonitis and remains a safe
technique for emergency colectomy in diverticular peri-
tonitis, and is especially useful in critically ill patients
and in patients with multiple comorbidities. However,
restoration of bowel continuity after a HP is associated
with significant morbidity and resource utilization [84].
As a result, many of these patients do not undergo re-
versal surgery and remain with a permanent stoma [85].
Common use of the HP in treating diverticular perfor-
ation worldwide is confirmed by a recent Australian
study analyzing administrative data of patients with
acute diverticulitis admitted, from 2009 to 2013, in eight
tertiary referral centers with specialist colorectal services
[86]. The HP was the most commonly performed emer-
gency operation, accounting for 72% of resections.
Another population-based retrospective cohort study
using administrative discharge data, conducted in On-
tario, Canada, was published in 2014 [87]. Among 18,
543 patients hospitalized with a first episode of diver-
ticulitis, from 2002 to 2012, 3873 underwent emergency
surgery. The use of laparoscopy increased (9 to 18%, p <
0.001), whereas the use of the HP remained unchanged
(64%), and like in the Australian study, was the most fre-
quently used operative approach in patients with compli-
cated acute diverticulitis.
In recent years, some authors have reported the role of
primary resection and anastomosis with or without a di-
verting stoma, in the treatment of acute diverticulitis,
even in the presence of diffuse peritonitis [88]. The deci-
sion regarding the surgical choice in patients with diffuse
peritonitis is generally left to the judgment of the sur-
geon, who takes into account the clinical condition and
the comorbidities of the patient. Studies comparing mor-
tality and morbidity of the HP versus primary anasto-
mosis did not show any significant differences. However,
most studies had relevant selection biases, as demon-
strated by four systematic reviews [89–91].
A study evaluating all patients with acute diverticulitis
undergoing emergent primary anastomosis with divert-
ing loop ileostomy and HP was recently published using
the ACS-NSQIP Colectomy Procedure Targeted Data-
base from 2012 to 2016 [92]. Out of 130,963 patients,
2729 patients were included. The median age was 64
years, and 48.5% were male; the majority of patients
underwent a HP, and only 208 (7.6%) underwent pri-
mary anastomosis with diverting loop ileostomy. Patients
undergoing a HP had more comorbidities [e.g., COPD
(9.8% vs. 4.8%, p = 0.017)], were more functionally
dependent [6.3% vs. 2.4%, p = 0.025], and were more
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unwell [e.g., septic shock (11.1% vs. 5.3%, p = 0.015)]
compared to primary anastomosis with diverting loop
ileostomy patients. The mortality rates for the patients
undergoing a HP versus primary anastomosis with di-
verting loop ileostomy were 7.6% and 2.9%, respectively
(p = 0.011). The morbidity rates were 55.4% and 48.6%,
respectively (p = 0.056). In multivariable analyses, com-
pared to the HP, primary anastomosis with diverting
loop ileostomy did not result in increased rates of mor-
tality (OR = 0.21, 95% CI 0.03–1.58, p = 0.129) or mor-
bidity (OR = 0.96, 95% CI 0.63–1.45, p = 0.834). The
authors concluded that primary anastomosis with divert-
ing loop ileostomy appears to be at least a safe alterna-
tive to the HP for select patient populations needing
emergent surgical management of acute diverticulitis.
A comparison of primary resection and anastomosis with
or without defunctioning stoma to the HP as the optimal
operative strategy for patients presenting with Hinchey
stage III–IV was published by Constantinides et al. [93]. A
total of 135 primary resection and anastomosis, 126 pri-
mary anastomosis with defunctioning stoma, and 6619 HPs
were considered in the study. Morbidity and mortality were
55% and 30% for primary resection and anastomosis, 40%
and 25% for primary anastomosis with defunctioning
stoma, and 35% and 20% for the HP. Stomas remained per-
manent in 27% of HPs and in 8% of primary anastomoses
with defunctioning stoma. The authors concluded that pri-
mary anastomosis with defunctioning stoma may be the
optimal strategy for selected patients with diverticular peri-
tonitis and may represent a good compromise between
postoperative adverse events, long-term quality of life, and
risk of permanent stoma.
A small randomized trial of primary anastomosis with ile-
ostomy versus a HP in patients with diffuse diverticular peri-
tonitis was published by Oberkofler et al. in 2012 [94]. Sixty-
two patients with acute left-sided colonic perforation
(Hinchey III and IV) from 4 centers were randomized to
Hartmann procedure (n = 30) and to primary anastomoses
with diverting ileostomy (n = 32). A planned stoma reversal
operation was performed after 3months in both groups. The
study reported no difference in initial mortality and morbid-
ity (mortality 13% vs. 9% and morbidity 67% vs. 75% in the
HP vs. primary anastomosis), but a reduction in length of
stay, lower costs, fewer serious complications, and greater
stoma reversal rates in the primary anastomosis group.
A multicenter RCT conducted between June 2008 and
May 2012, the DIVERTI (Primary vs. Secondary Anasto-
mosis for Hinchey Stage III-IV Diverticulitis) trial [95],
was published in 2017. All 102 patients enrolled were
comparable for age (p = 0.4453), sex (p = 0.2347), Hinchey
stage III vs. IV (p = 0.2347), and Mannheim Peritonitis
Index (p = 0.0606). Overall mortality did not differ signifi-
cantly between the HP (7.7%) and primary anastomosis
(4%) (p = 0.4233) groups. Morbidity for both resection
and stoma reversal operations was comparable (39% in
the HP arm vs. 44% in the primary anastomosis arm; p =
0.4233). At 18months, 96% of primary anastomosis pa-
tients and 65% of the HP patients had a stoma reversal (p
= 0.0001). Although mortality was similar in both arms,
the rate of stoma reversal was significantly higher in the
primary anastomosis arm. This trial provides additional
evidence in favor of primary anastomosis with diverting
ileostomy over the HP in patients with diverticular
peritonitis.
In 2019, the results of the LADIES study [96] demon-
strated that in hemodynamically stable, immunocompe-
tent patients younger than 85 years, primary anastomosis
is preferable to the HP as a treatment for perforated di-
verticulitis (Hinchey III or Hinchey IV disease). Patients
aged between 18 and 85 years who presented with clin-
ical signs of general peritonitis and suspected perforated
diverticulitis were eligible for inclusion if plain abdom-
inal radiography or CT scan showed diffuse free gas or
fluid. Patients with Hinchey I or II diverticulitis were not
eligible for inclusion. Patients were allocated (1:1) to the
HP or sigmoidectomy with primary anastomosis, with or
without defunctioning ileostomy. The 12-month stoma-
free survival was significantly better for patients under-
going primary anastomosis compared with the HP
(94.6% [95% CI 88.7–100] vs. 71.7% [95% CI 60.1–83·3],
hazard ratio 2.79 [95% CI 1·86–4.18]; log-rank p <
0·0001). There were no significant differences in short-
term morbidity and mortality after the index procedure
for the HP compared with primary anastomosis (mor-
bidity, 29 [44%] of 66 patients vs. 25 [39%] of 64, p =
0.60; mortality, two [3%] vs. four [6%], p = 0.44).
Recently, a systematic review of the existing literature
about surgical management of Hinchey III and IV diver-
ticulitis was published [97]. A total of 25 studies involv-
ing 3546 patients were included in this study. The
overall mortality in patients undergoing a HP was 10.8%
across the observational studies and 9.4% in the RCTs.
The mortality rate in patients undergoing a primary
anastomosis was lower than that in the HP group, at
8.2% in the observational studies and 4.3% in the RCTs.
A comparison of primary anastomosis with the HP dem-
onstrated a 40% lower mortality rate in the primary
anastomosis group than in the HP group (OR 0.60, 95%
CI 0.38–0.95, p = 0.03), when analyzing the observa-
tional studies. However, meta-analysis of the RCTs did
not demonstrate any difference in mortality. Wound in-
fection rates between the two groups were comparable.
Should laparoscopic resection be preferred to
open resection in patients with diffuse peritonitis
due to perforated diverticulitis?
In patients with diffuse peritonitis due to perforated di-
verticulitis, we suggest to perform an emergency
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laparoscopic sigmoidectomy only if technical skills and
equipment are available (weak recommendation based
on low-quality evidence, 2C).
Laparoscopic sigmoidectomy for diverticulitis had ini-
tially been confined to the elective setting. However, in
physiologically stable patients, laparoscopic sigmoidect-
omy may be feasible in the setting of purulent and fecal
diverticular peritonitis. In 2015, a systematic review on
laparoscopic sigmoidectomy for diverticulitis in the
emergency setting was published [98].
The review included 4 case series and one cohort
study (total of 104 patients) out of 1706 references. A
HP was performed in 84 patients, and primary anasto-
mosis was fashioned in 20 patients. The mean operating
time varied between 115 and 200 min. The conversion
to open surgery rate varied between 0 and 19%. The
mean length of hospital stay ranged between 6 and 16
days. Surgical re-intervention was necessary in 2 pa-
tients. In 20 patients operated upon without defunction-
ing ileostomy, no anastomotic leakage was reported.
Three patients died during the postoperative period.
Stoma reversal after HP was performed in 60 out of 79
evaluable patients (76%).
These guidelines are limited by the low-quality evi-
dence that showed that emergency laparoscopic sigmoi-
dectomy for the treatment of perforated diverticulitis
with generalized peritonitis is feasible. These studies oc-
curred in selected patients and in experienced units and
are not generalizable to all centers. High-quality pro-
spective or randomized studies are needed to demon-
strate benefits of emergency laparoscopic sigmoidectomy
compared to open sigmoidectomy for perforated
diverticulitis.
Should damage control surgery with staged
laparotomies be recommended in patients with
acute peritonitis due to diverticular perforation?
We suggest damage control surgery (DCS) with staged
laparotomies in selected unstable patients with diffuse
peritonitis due to diverticular perforation (weak recom-
mendation based on low-quality evidence, 2C).
A damage control surgical strategy may be useful for
patients in physiological extremis from abdominal sepsis
[99]. The initial surgery focuses on control of the sepsis,
and a subsequent operation deals with the anatomical
restoration of the gastrointestinal tract, after a period of
physiological resuscitation. This strategy facilitates both
the control of the severe sepsis control as well as poten-
tially improving the rate of primary anastomosis [100].
Generalized diverticular peritonitis is a life-threatening
condition requiring prompt emergency operation. To
improve outcomes and reduce the rate of colostomy for-
mation, a new algorithm for damage control operation,
lavage, limited resection or closure of perforation, and
second look surgery to restore intestinal continuity was
developed in recent years [101, 102]. Some patients may
be physiologically deranged. These patients, who are
hemodynamically unstable, are not optimal candidates
for immediate complex operative interventions. After
initial surgery, which should be limited to source con-
trol, e.g., primary closure of the perforation/local resec-
tion of the diseased bowel, the patient is taken to the
intensive care unit (ICU) for physiologic optimization.
However, this strategy will also delay bowel anastomosis
to a period of physiological stability [103] potentially
changing the intraoperative physiological milieu, poten-
tially favoring a primary anastomosis, and avoiding the
formation of a stoma altogether. In the setting of acute
diverticulitis, several reports (with low level of evidence)
were published. In 2010, a prospective observational
study was published by Kafka-Ritsch et al. [101]. A total
of 51 patients (28 females 55%) with a median age of 69
(range 28–87) years, with perforated diverticulitis
Hinchey III (n = 40, 78%) or Hinchey IV (n = 11, 22%),
were prospectively enrolled in the study. Patients were
initially managed with limited resection, lavage, and tem-
porary abdominal closure followed by second, recon-
structive operation 24–48 h later, which are supervised
by a colorectal surgeon. Bowel continuity was restored
in 38 (84%) patients, of which four were protected by a
loop ileostomy. Five anastomotic leaks (13%) were en-
countered requiring loop ileostomy in two patients and
a HP in remaining three patients. The overall mortality
rate was 9.8%, and 35 of 46 surviving patients (76%) left
the hospital with reconstructed colon continuity. Fascial
closure was achieved in all patients.
Sohn et al. performed a case-control study comparing
traditional strategy versus damage control: there were no
differences in morbidity and mortality, but there was a
significant reduction of stoma creation in the damage
control group [104].
Despite promising experiences, little robust or large-
scale data are available, and the open abdomen and
damage control strategy are not without risk: for ex-
ample, such procedures are associated with the forma-
tion of entero-atmospheric fistula and high costs, among
other issues. Guidelines recommend this strategy only in
critically ill patients who cannot withstand major sur-
gery. Although there is now a biologic rationale for such
an intervention as well as non-standardized and erratic
clinical utilization, this remains a novel therapy with po-
tential side effects and clinical equipoise. The WSES rec-
ommends to use an open abdomen approach in selected
significantly physiologically deranged patients with on-
going sepsis [105]. The Closed Or Open after Laparot-
omy (COOL) study constitutes a prospective RCT that
will randomly allocate eligible surgical patients intraop-
eratively to either formal closure of the fascia or use of
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the open abdomen with application of with active negative
peritoneal pressure therapy. This trial will be powered to
demonstrate a mortality difference in this highly lethal
and morbid condition to ensure critically ill patients are
receiving the best care possible and not being harmed by
inappropriate therapies based on opinion only [106].
What factors should be considered in planning
elective resection in cases of acute diverticulitis
treated non-operatively?
We suggest evaluating patient-related factors and not
number of previous episodes of diverticulitis in planning
elective sigmoid resection (weak recommendation based
on very low-quality evidence, 2D).
After an episode of ALCD treated conservatively, we sug-
gest planning of an elective sigmoid resection in high-risk
patients, such as immunocompromised patients (weak rec-
ommendation based on very low-quality evidence, 2D).
Recurrence of acute diverticulitis is lower than previously
thought. Historically, it has been reported that about one
third of all patients with acute diverticulitis will have a re-
current attack, often within 1 year [107, 108]. However, the
recurrence after an uncomplicated episode of diverticulitis
appears much lower: with a recent prospective study re-
ported a recurrence of only 1.7% over 5 years of follow-up
[109, 110]. After a follow-up of 4 years, El Sayed et al. [111],
in an English study of over 65,000 patients managed non-
operatively for their first episode of diverticulitis, found the
recurrence rate to be around 11.2%. Emergency and elective
colectomy rates were 0.9 and 0.75%, respectively. Female
gender, young age, smoking, obesity, and complicated initial
disease were risk factors for readmission and emergency
surgery. The study also pointed out that some factors asso-
ciated with recurrence are modifiable; weight reduction and
smoking cessation can be championed.
In 2014, a systematic review of studies reviewing the
diagnosis and management of chronic and recurrent di-
verticulitis (from studies published between January 2000
to March 2013) was published [112]. The 68 studies in-
cluded were almost exclusively observational and had lim-
ited certainty of treatment effect. The authors found that
complicated recurrence after recovery from an uncompli-
cated episode of diverticulitis was rare (< 5%) and that age
at onset younger than 50 years and 2 or more recurrences
did not increase the risk of complications.
The authors concluded that the indication for elective
colectomy following 2 episodes of diverticulitis is no lon-
ger accepted. Indication to colectomy should be made
based on consideration of the risks of recurrent diver-
ticulitis, the morbidity of surgery, ongoing symptoms,
the complexity of disease, and operative risk.
A recent open-label randomized multicenter trial (DIR-
ECT trial) randomized 109 patients from 24 teaching and
two academic hospitals in the Netherlands presenting with
recurrent and persisting abdominal complaints after an
episode of diverticulitis to receive surgical treatment or
non-operative management [113]. After a brief follow-up
of 6months, elective sigmoidectomy resulted in a better
quality of life (assessed by many specific questionnaires)
compared to non-operative management. However, the
results of the study may be affected by the heterogeneity
of patients enrolled (patients with both recurrent diver-
ticulitis and patients with persistent abdominal
complaints).
Currently, the decision to perform an elective resec-
tion after one or more episodes of AD should be under-
taken on a case-by-case basis, taking into account risk
factors, complications, age, and severity of episodes as
well as the patient’s personal circumstances and comor-
bidities (e.g., immunosuppressed patients) [114].
What is the optimal antibiotic therapy for
patients with diffuse peritonitis due to
diverticular perforation? What is the optimal
duration of antibiotic therapy after surgical
source control in diffuse peritonitis due to
diverticular perforation?
We suggest to choose the empirically designed antibiotic
regimen on the basis of the underlying clinical condition
of the patient, the pathogens presumed to be involved,
and the risk factors for major antimicrobial resistance
patterns (strong recommendation based on moderate-
quality evidence, 1B).
We suggest a 4-day period of postoperative antibiotic
therapy in complicated ALCD if source control has been
adequate (weak recommendation based on moderate-
quality evidence, 2B).
Antibiotic therapy plays an important role in the man-
agement of complicated acute diverticulitis. Typically, it
is an empiric antibiotic treatment. The regimen should
depend on the severity of infection, the pathogens pre-
sumed to be involved, and the risk factors indicative of
major resistance patterns [39]. Several recommendations
have been recently published in literature [39]. However,
consideration of local epidemiological data and resist-
ance profiles is essential for antibiotic selection.
Considering intestinal microbiota of large bowel acute di-
verticulitis requires antibiotic coverage for Gram-positive
and Gram-negative bacteria, as well as for anaerobes. Most
of the complicated acute diverticulitis is mainly a
community-acquired infection. The main resistance threat
in IAIs is posed by extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae, which are becoming
increasingly common in community-acquired infections
worldwide [33]. The most significant risk factors for ESBL-
producing pathogens include prior exposure to antibiotics
and comorbidities requiring concurrent antibiotic therapy
[39]. Anti-ESBL-producer coverage should be warranted
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for patients with these risk factors. Discontinuation of anti-
biotic treatment should be at 4 days from source control as
this has been demonstrated as non-inferior to longer ther-
apy based on the STOP IT trial [115].
The recent prospective trial by Sawyer et al. demon-
strated that in patients with complicated IAIs undergoing
an adequate source-control procedure, the outcomes after
approximately 4 days fixed-duration antibiotic therapy were
similar to those after a longer course of antibiotics that ex-
tended until after the resolution of physiological abnormal-
ities [115].Patients who have signs of sepsis beyond 5 to 7
days of adequate antibiotic treatment warrant aggressive
diagnostic investigation in search of a reservoir of infection.
Which are the principles of the treatment of acute
right-sided colonic diverticulitis?
Although studies have shown that the percentage of com-
plications requiring surgery is higher in patients with
ALCD than in patients with ARCD, the principles of
diagnosis and treatment of patients with ARCD are simi-
lar to those with ALCD. We suggest that all the state-
ments for ALCD also apply to ARCD.
Acute colonic diverticulitis is a common condition af-
fecting the adult population. Traditionally, the sigmoid
colon is considered the most commonly involved part,
and ARCD is much rarer [116]. However, in some re-
gions of the world, ARCD outnumber ALCD [116]. The
ARCD differs from the ALCD in some aspects. The
former is usually solitary [29, 117], and has a low rate of
complicated diverticulitis [118].
ARCD generally occurs in middle-aged men, and its
incidence does not increase with age. Especially the
ARCD located in the cecum, it is difficult to distinguish
ARCD from acute appendicitis because of their similar
symptoms and signs.
CT scanning appears to be the best overall imaging mo-
dality in the diagnosis of possible ARCD [119, 120]. How-
ever, US is more economic than CT and poses no radiation,
which may be particularly important since the patients hav-
ing right-sided diverticulitis are relatively younger.
US features, including diverticular wall thickening, sur-
rounding echogenic fat, and intra-diverticular echogenic
material, can provide clear information for making cor-
rect preoperative diagnosis. However, US is operator
dependent. Ambiguous US studies may be complemen-
ted with a contrast-enhanced CT [121].
Currently, the management of ARCD is not well de-
fined, and no unique guidelines have been proposed.
Although previous studies have shown that the per-
centage of complications requiring surgery is higher in
patients with ALCD than in patients with ARCD [122],
the principles of diagnosis and treatment of ARCD are
very similar to those of ALCD. As a treatment option,
non-operative methods should be preferred, in cases
without diffuse peritonitis although differentiating benign
and malignant cases pre-operatively is often difficult [123].
Surgical treatment is usually used in the treatment of
complicated cases [116, 124, 125]. Resection of the in-
flamed colon with primary anastomosis can be performed
by laparoscopy in experienced centers [126].
Conclusions
ALCD is a common problem encountered by Western
surgeons in the acute setting. The sigmoid is usually the
most commonly involved colonic segment, while ARCD is
much rarer.
An international multidisciplinary panel of experts from
the World Society of Emergency Surgery (WSES) updated
its guidelines on the management of acute left-sided co-
lonic (ALCD) diverticulitis according to the most recent
available literature. The update includes recent changes
introduced in the management of ALCD. The new update
contains a section on ARCD, which is more prevalent than
ALCD in some regions of the world.
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